{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Nimodipine in Clinical Practice: A Pharmacological Update

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Choose the most common adverse effect of nimodipine.
  2. Identify the administration protocols recommended for the use of nimodipine.
  3. Select the appropriate intervention for patients who have developed cerebral vasospasm.
  4. Recognize a common drug-drug interaction with nimodipine.

Learning Outcomes

75% of participants will demonstrate knowledge of the use of nimodipine to treat aneurysmal subarachnoid hemorrhage, including factors to consider for dosing and administration, pharmacokinetic impact, and drug interactions, by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $21.95


  • ANCC 2.0 CH / 2.0 APH
  • DC - BON 2.0 CEH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: JNN0222
Published: Feb 2022
Expires: 12/6/2024
Required Passing Score: 7/10 (70%)
Authors: Brendon Clough, PharmD; Josephine Tenii, PharmDBCPS BCCCP; Claribel Wee, MD; Elizabeth Gunter, BSN RN CCRN SCRN; Tara Griffin, BSN RN SCRN; Venkatesh Aiyagari, MD